New hires and promotions in the biopharma industry in Asia-Pacific, including: Adagene.

Regulatory snapshots, including drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations in Asia-Pacific: Biophytis, Cstone, Eisai, Genfleet, Mabwell, Priothera, Ractigen, Valeo, Valneva.

Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief: Abbisko, Allist, Amarin, Annji, Atea, Avenue, Biogen Japan, Catalyst, CSL, CSL Seqirus, Eisai, GC, Inspirevax, Landos, Lianbio, Oragenics.

Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Amniotics, Atom, Brim, CSL, CSL Behring, Elpiscience, Hutchmed, Innovent, Junshi, JW, Karolinska, SFB Vaccines.

Biopharmas in Asia-Pacific raising money in public or private financings: Akeso, Austrianova, Oricell, SG Austria, Summit.

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Coherus, Neuromod Devices, X-Bolt.

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Auxocell, Biostem, Caredx, Caris Life Sciences, Electrocore, Fulton Ventures, Incyte, KLS Martin, Lucius Partners, Mellingmedical, Miach Orthopaedics, PD Theranostics, Rocket VR Health.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Catalyst, Galvanize, Inari, Masimo.

Med-tech firms raising money in public or private financings, including: Paragonix, Resuture.

New hires and promotions in the med-tech industry, including: Biological Dynamics, Curavit, IMA Group, Mediwound.